Target intelligence / Profile preview

General gastrointestinal contents

Molecular classification
Other
01

Overview

General gastrointestinal contents refers to the heterogeneous mixture of food, fluids, enzymes, and microorganisms within the lumen of the digestive tract (StatPearls). While not a specific molecular target like a receptor or enzyme, it serves as the primary site of action for various pharmacological agents that exert their effects through physical or chemical interactions (PubChem). For example, activated charcoal acts by adsorbing toxins within the gastric and intestinal lumen to prevent systemic absorption (StatPearls). Similarly, bulk-forming and osmotic laxatives modify the physical properties of these contents to facilitate bowel movements (Mayo Clinic). Phosphate binders like sevelamer and lipid-blockers like orlistat also target the contents directly to sequester specific dietary components (FDA). Because these treatments act on the bulk environment of the gut, they often carry a risk of interfering with the absorption of other essential medications and nutrients (NIH). This target is therefore characterized by non-specific, luminal interactions rather than high-affinity binding to a single biological macromolecule.

Other names
GI contentsGastric contentsIntestinal contentsChymeLuminal contentsFecal matter
02

Mechanism of action

Drugs interact with these contents via physical adsorption of toxins, chemical neutralization of acid, osmotic retention of water, or binding of specific dietary components to prevent systemic absorption (StatPearls, PubChem).

03

Biological functions

DigestionNutrient absorptionWaste excretionMicrobiome habitat
04

Disease associations

PoisoningHyperphosphatemiaConstipationFlatulenceSteatorrhea
05

Safety considerations

Drug-drug interactions due to adsorption (NIH)Electrolyte imbalance (Mayo Clinic)Intestinal obstructionMalnutrition
06

Interacting drugs

Activated charcoal

6 more in the full profile.

07

Biomarkers

Gastric pHStool consistencySerum phosphate levelsFecal fat content

Beyond the preview

Go deeper on General gastrointestinal contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General gastrointestinal contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call